MDRNA Soaring (MRNA)

Posted in pre-market 
January 26th, 2010

MDRNA, Inc. (NASDAQ: MRNA) is trading higher after the company noted that the State Intellectual Property Office of China issued a Notification of Granting Patent Rights for the use of nucleic acids and siRNA for a cancer treatment.  This is against tumor progression and metastatic disease.

Shares closed at $0.97 yesterday and the stock is up 20.6% at $1.17 on 543,000 shares as of 8:32 AM EST.  The 52-week range is $0.22 to $3.55 and the average volume is 1.34 million shares.


Comments are closed